risedronic acid has been researched along with Dermatitis Medicamentosa in 1 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bianchi, L | 1 |
| Hansel, K | 1 |
| Romita, P | 1 |
| Foti, C | 1 |
| Stingeni, L | 1 |
1 other study available for risedronic acid and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Erythema multiforme-like eruption induced by risedronate.
Topics: Bone Density Conservation Agents; Drug Eruptions; Erythema Multiforme; Female; Humans; Middle Aged; | 2017 |